Skip to content

The effects of Mawangdui therapy on the pulmonary function, physical fitness levels and quality of life in stable Chronic Obstructive Pulmonary Disease (COPD) patients

The effects of Mawangdui therapy on the pulmonary function, physical fitness levels and quality of life in stable Chronic Obstructive Pulmonary Disease (COPD) patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006687
Enrollment
Unknown
Registered
2022-10-06
Start date
2022-10-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Control Group:Participants in the control group continue to receive their usual medical treatment. They were advised to maintain their routine activities. No extra exercise will be recommended.
Intervention Group:Participants in the invention group completed a 3-month Mawangdui exercise program in addition to usual medical treatment. Mawangdui exercise consists of 12 low-impact movements whi

Sponsors

Pan Xiaoyan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age range 50-70 years old. 2. COPD patient admitted to Changde First Hospital of Traditional Chinese Medicine. 3. COPD patients in mild to moderate remission classification (stage I or II). At the same time, the patients are in a stable stage, namely, the symptoms such as cough and shortness of breath are well managed, and pulmonary decline is minimised. Medical doctors will select patients who meet the inclusion criteria.

Exclusion criteria

Exclusion criteria: 1. Patients with severe liver and kidney damage. 2. Recent use of immunosuppressants. 3. Not suitable for physical exercise (assessed via Physical Activity Readiness Medical Examination, PARmed-X+) . 4. Patients needing ventilation or oxygen therapy. 5. Patients with poor compliance (<80% attendance) and unable to finish the 6-month course of exercise intervention treatment.

Design outcomes

Primary

MeasureTime frame
St. George's Respiratory Questionnaire (SGRQ);COPD assessment test (CAT);Muscle strength test;Pulmonaryfunction evaluation indexes;Dyspnoea scale assessment;6-minute walking test (6MWT);Sit-and-reach flexibility test;

Secondary

MeasureTime frame
Anthropometry measurement;

Countries

China

Contacts

Public ContactPan Xiaoyan
897846734@qq.com13875854636

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026